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208every single patient in accordance to his aortic
contrast medium attenuation.
In this dataset (n ¼ 110), we performed a linear
regression model depending on the individual HU
threshold and the ratio between the calcium
measurements in CTA and nonenhanced scans. The
regression line showed a slope of –0.0003 and
an intercept with the Y-axis at 0.4065. Hence, the
calibration factor (CF) for calcium quantification
in CTA scans was calculated as follows:
calibration factor ¼ 1ðindividual HU threshold  slopeÞ
þ Y-axis intercept
The derived CTA volumes of aortic calcifications
using the þ100% HU threshold above the intravas-
cular density were then multiplied by the individual
CF. For validation purposes, the accuracy of this
approach was determined in additional 100 conse-
cutive patients undergoing CT for TAVR planning
(Figure 1A).
Overall, 78 patients (13.3%) presented with
SCALVOT. The composite clinical endpoint occurred
more frequently in the SCALVOT group (Figure 1B).
Furthermore, patients with SCALVOT showed higher
incidence of more than mild PVL (2.4% vs. 6.4%,
p ¼ 0.046) and were at higher risk of 30-day and
2-year all-cause mortality (2.4% vs. 9.0%, log-rank
p ¼ 0.001; 22.6% vs. 32.8%, log-rank p ¼ 0.019,
respectively). In multivariate model, SCALVOT was
identified as independent predictor of the 30-day
composite endpoint (hazard ratio [HR]: 2.44; 95%
confidence interval [CI]: 1.26 to 4.73) and 2-year
mortality (HR: 1.86; 95% CI: 1.17 to 2.93).
Although the threshold of 609 mm3 LVOT calcium
volume was derived and validated in the same cohort,
additional confirmation in an independent popula-
tion is required. In addition, our results have to be
interpreted within the context of a specific contrast
protocol on specific scanner platforms. However, by
application of this novel standardized method for
calcium quantification from CTA images, we were
able to confirm SCALVOT as important risk factor of
30-day adverse events as well as short-term and
mid-term mortality in patients undergoing TAVR with
BEV. This finding underlines the important clinical
role of accurate pre-TAVR assessment and risk
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Significance of Effective Prosthetic Orifice
Area After Aortic Valve ReplacementThe definition of prosthesis–patient mismatch (PPM)
remains to be refined to enhance its prognosis insight
after surgical aortic valve replacement (SAVR) for
severe aortic stenosis, especially in obese patients (1).
We aimed at investigating the respective prevalence
and prognostic value of effective orifice area (iEOA)
and industry-predicted orifice area (iPOA) normalized
to body surface area, according to the body weight
status after SAVR. We hypothesized that the iEOA
would bring increased prognostic insight as compared
with the iPOA, regardless of the body weight status.
Between 2009 and 2016, we prospectively explored
all consecutive patients referred to our Heart Valve
Clinic for a first SAVR who presented severe aortic
stenosis and a normal left ventricular ejection frac-
tion (>50%). The iPOA predicted from reference
normal value (2) and iEOA calculated by transthoracic
echocardiography were assessed at discharge. PPM
was defined with current definitions, that is, moder-
ate for 0.65 cm2/m2 # iOA #0.85 cm2/m2 and severe
for iOA #0.65 cm2/m2. Patients were followed for
major events (ME), defined as cardiovascular death,
hospitalization for heart failure, and stroke.














p = 0.04 by log-rank test for trend






















































p = 0.17 by log-rank test for trend















































p = 0.0002 by log-rank test for trend








































Event-free survival according to the industry-predicted orifice area
(iPOA) (A) and the effective orifice area (iEOA) (B). Moderate and
severe prosthesis–patient mismatch (PPM) were defined according
to standard definitions in A and B. (C) Event-free survival
according to iEOA in obese patients with PPM defined according
to the receiver-operating characteristic curve derived cut-off of
0.85 cm2/m2.
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209There were 762 patients included, with the iPOA
available in 712 patients (93.4%). The mean age was
70  11 years with 54% male; one-quarter had dia-
betes. Two-thirds were overweight (37%) or obese
(33%). EuroSCORE II were low, 1.36 (Q1: 0.95 to Q3:
2.15), and similar between lean, overweight, and
obese patients (p ¼ 0.86). The proportions of biolog-
ical prosthesis (almost 80%) and concomitant coro-
nary bypass grafting (almost 25%) were the same in
the different body status groups (p ¼ 0.81 and p ¼
0.51, respectively). The mean diameter of the pros-
thetic valve was 22.5  2.0 mm.
The prevalence of patient without significant PPM
was the same using iEOA or iPOA (46.9% vs. 47.5%; p ¼
0.83). Conversely, severe PPM was almost 3 times more
frequently observed with iEOA than with iPOA (20.5%
vs. 7.0%; p < 0.0001). with a significant but weak corre-
lation between these 2 parameters (p< 0.0001; r2 ¼ 0.21).
During a mean follow-up of 4.0  2.5 years, ME
occurred in 134 patients (17.6%) with 44 cardiovascular
deaths and 100 acute heart failures (n ¼ 73) and strokes
(n¼ 52). PPM as defined with iPOAwas barely associated
with ME occurrence (Figure 1A). Importantly, neither
moderate nor severe PPM defined with iPOA (hazard
ratio [HR]: 1.44; 95% confidence interval [CI]: 0.99 to
2.09; p ¼ 0.06) were significantly associated with
increased occurrence of ME in comparison with the pa-
tients free from PPM (HR: 1.55; 95% CI: 0.75 to 3.20; p ¼
0.16). Conversely, PPM as defined by iEOA was signifi-
cantly associated with ME occurrence (Figure 1B): mod-
erate (HR: 1.97; 95% CI: 1.29 to 2.99; p ¼ 0.0005) and
severe PPM (HR: 1.97; 95% CI: 1.20 to 3.24; p ¼ 0.0017)
were significantly associated with worse long-term
prognosis with versus without PPM. Surprisingly, no
prognostic difference was observed between moderate
and severe PPM (p ¼ 0.81), questioning the reference
value to define PPM. After multivariable adjustment
including variables with a p value of <0.10 on Cox uni-
variate analysis (i.e., age, body mass index, diabetes,
hypertension, and iEOA), older age (b SE¼ 0.04 0.01;
p¼ 0.0003), high bodymass index (b SE¼ 0.04 0.02;
p ¼ 0.02), diabetes (HR: 1.95; 95% CI: 1.33 to 2.85; p ¼
0.0006) and low iEOA (b  SE ¼ 0.71  0.33; p ¼ 0.03)
were independently associated with long-term occur-
rence of ME. Receiver-operating characteristic curve
analysis showed that a cut-off (maximum Youden index
criteria) of 0.85 cm2/m2 for iEOA had the greater
discriminating power to predict ME onset without being
a strong prognosticator (area under the curve: 0.58;
p¼0.018). An iEOA<0.85 cm2/m2was associatedwith an
increased occurrence ofME in lean (HR: 2.12; 95%CI: 1.01
to 4.48; p ¼ 0.03) and overweight (HR: 1.92; 95% CI: 1.08
to 3.40; p ¼ 0.03), but not in obese patients (HR: 1.47;
95% CI: 0.86 to 2.51; p ¼ 0.17) (Figure 1C).
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210To explore further the lack of prognostic insight of
iEOA in obese patients, we tested the indexation of
EAO by different power of height to refine PPM defi-
nition in this group thanks to an accelerated failure
time nonlinear model with hazard: S(t) ¼ exp([a$t]g)
and a ¼ exp(b0 þ b1$EOA/heightb2); b0, b1, b2, and g
were optimized by NLMIXED SAS procedure (SAS,
Inc., Chicago, Illinois).
Surprisingly, EOA normalized to the height
elevated to the power of b2 was not significantly
associated with ME occurrence in obese patients
whatever b2 value, that is, ME after SAVR were not
driven by prosthetic orifice area in obese patients,
suggesting an “obesity paradox.”
To conclude, indexing the EOA derived from TTE
measurements by body surface area with the unique
cutoff of 0.85 cm2/m2 showed the best accuracy to
predict ME after SAVR and might be preferred to
constructors-generated orifice area reference
values. Importantly, a clear association between
echocardiography-derived EOA and cardiac events
was only observed in lean and overweight patients but
not in obese, regardless of the indexation calculation.
Further studies are needed to explore the lack of
prognostic insight of PPM in obese patients.Augustin Coisne, MD*
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Aortic Root in Patients With Bicuspid and
Tricuspid Aortic Valve StenosisDoes Fusion of Doppler-Echocardiography andComputed Tomography Resolve Discordant Severity Grading?
Up to 30% of patients with aortic stenosis (AS) present
with discordant grading (aortic valve area [AVA] <1
cm2, but the mean pressure gradient [MPG] $40
mm Hg), raising uncertainty regarding the degree of
AS severity (1). The aortic root is elliptical and trans-
thoracic echocardiography (TTE)-derived left ven-
tricular outflow tract (LVOT) area may be
underestimated as based on a single diameter
(TTELVOTd) (2). Combining computed tomography(CT)
measurement of the LVOT area with TTE hemody-
namic parameters has been proposed to solve the
issue of discordant grading (3).
We enrolled 70 consecutive patients with moder-
ate/severe bicuspid AS and 140 sex-, body surface
area-, and MPG-matched patients with moderate/se-
vere tricuspid AS. The AVAECHO was calculated using
the continuity equation as: P/4  (TTELVOTd)2 
VTILVOT/VTIAV (where VTI is the velocity–time inte-
gral and AV is aortic valve). Using CT scans, from the
true double oblique transverse view, maximum
(Dmax) and minimal (Dmin) diameters, and annulus
area (CTLVOTarea) were measured and eccentricity in-
dex (1  [Dmin/Dmax]) was calculated. Fused AVA
(AVACT) was calculated as: CTLVOTarea  VTILVOT/
VTIAV.
The MPG was 53  15 mm Hg, AVAECHO was 0.77 
0.20 cm2, and 180 patients (86%) presented with an
AVA <1 cm2. By design, there was no difference in
